Mass spectrometry in emergency toxicology: Current state and future applications

References

• Gummin DD, Mowry JB, Spyker DA, et al. 2016 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th Annual Report. Clin Toxicol (Phila). 2017;55:1072–1252.
   PubMed Web of Science ®Google Scholar
• Albert M, McCaig LF, Uddin S. Emergency department visits for drug poisoning: United States, 2008-2011. NCHS Data Brief. 2015;196:1–8.
   Google Scholar
• Nelson LS, Lewin NA, Howland MA, et al. Goldfrank’s Toxicologic Emergencies. 9th ed. New York: McGraw-Hill Medical; 2011. Chapter 3, Initial evaluation of the patient: vital signs and toxic syndromes; p. 33–36.
   Google Scholar
• Nelson LS, Lewin NA, Howland MA, et al. Goldfrank’s Toxicologic Emergencies. 9th ed. New York: McGraw-Hill Medical; 2011. Chapter 4, Principles of managing the acutely posioned or overdosed patient; p. 37–44.
   Google Scholar
• Rege SV, Ngo DA, Ait-Daoud N, et al. Trends and characteristics of naloxone therapy reported to US poison centers. Addiction. 2018;113:2309–2315.
   PubMed Web of Science ®Google Scholar
• Boyle JS, Bechtel LK, Holstege CP. Management of the critically poisoned patient. Scand J Trauma Resusc Emerg Med. 2009;17:29.
   PubMed Web of Science ®Google Scholar
• Wu AHB. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003;49:357–379.
   PubMed Web of Science ®Google Scholar
• Thomas SHL, Watson ID. Laboratory analyses for poisoned patients. Ann Clin Biochem. 2002;39:327.
   PubMed Web of Science ®Google Scholar
• Thompson JP, Watson ID, Thanacoody HKR, et al. Guidelines for laboratory analyses for poisoned patients in the United Kingdom. Ann Clin Biochem. 2014;51:312–325.
   PubMed Web of Science ®Google Scholar
• Wiencek JR, Colby JM, Nichols JH. Rapid assessment of drugs of abuse. Adv Clin Chem. 2017;80:193–225.
   PubMed Web of Science ®Google Scholar
• Lewandrowski K, Flood J, Finn C, et al. Implementation of point-of-care rapid urine testing for drugs of abuse in the emergency department of an academic medical center: impact on test utilization and ED length of stay. Am J Clin Pathol. 2008;129:796–801.
   PubMed Web of Science ®Google Scholar
• Watson ID, Bertholf RL, Hammett-Stabler C. Drugs and ethanol testing at the point of care: point care J. Patient Test Technol. 2007;6:227–230.
   Google Scholar
• Mastrovitch TA, Bithoney WG, DeBari VA, et al. Point-of-care testing for drugs of abuse in an urban emergency department. Ann Clin Lab Sci. 2002;32:383–386.
   PubMed Web of Science ®Google Scholar
• Kranzler HR, Stone J, McLaughlin L. Evaluation of a point-of-care testing product for drugs of abuse; testing site is a key variable. Drug Alcohol Depend. 1995;40:55–62.
   PubMed Web of Science ®Google Scholar
• Attema-de Jonge ME, Peeters SYG, Franssen EJF. Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department. J Emerg Med. 2012;42:682–691.
   PubMed Web of Science ®Google Scholar
• Melanson SEF. Drug-of-abuse testing at the point of care. Clin Lab Med. 2009;29:503–509.
   PubMed Web of Science ®Google Scholar
• Tomaszewski C, Runge J, Gibbs M, et al. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity. J Emerg Med. 2005;28:389–394.
   PubMed Web of Science ®Google Scholar
• Yang JM, Lewandrowski KB. Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT). Clin Chim Acta Int J Clin Chem. 2001;307:27–32.
   PubMed Web of Science ®Google Scholar
• Phillips JE, Bogema S, Fu P, et al. Signify ER drug screen test evaluation: comparison to Triage Drug of Abuse Panel plus tricyclic antidepressants. Clin Chim Acta. 2003;328:31–38.
   PubMed Web of Science ®Google Scholar
• Koch TR, Raglin RL, Kirk S, et al. Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse. J Anal Toxicol. 1994;18:168–172.
   PubMed Web of Science ®Google Scholar
• Beck O, Carlsson S, Tusic M, et al. Laboratory and clinical evaluation of on-site urine drug testing. Scand J Clin Lab Invest. 2014;74:681–686.
   PubMed Web of Science ®Google Scholar
• Kerrigan S, Phillips WH. Comparison of ELISAs for opiates, methamphetamine, cocaine metabolite, benzodiazepines, phencyclidine, and cannabinoids in whole blood and urine. Clin Chem. 2001;47:540–547.
   PubMed Web of Science ®Google Scholar
• Verstraete AG. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit. 2004;26:200–205.
   PubMed Web of Science ®Google Scholar
• Rainey PM. Goldfrank’s toxicologic emergencies. 9th ed. New York: McGraw-Hill Medical; 2011. Chapter 6, Laboratory principles; p. 70–89.
   Google Scholar
• Reisfield GM, Goldberger BA, Bertholf RL. “False-positive” and “false-negative” test results in clinical urine drug testing. Bioanalysis. 2009;1:937–952.
   PubMed Web of Science ®Google Scholar
• Saitman A, Park H-D, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38:387–396.
   PubMed Web of Science ®Google Scholar
• Durback LF, Scharman EJ, Brown BS. Emergency physicians perceptions of drug screens at their own hospitals. Vet Hum Toxicol. 1998;40:234–237.
   PubMedGoogle Scholar
• Reisfield GM, Bertholf R, Barkin RL, et al. Urine drug test interpretation: what do physicians know? J Opioid Manag. 2007;3:80–86.
   PubMedGoogle Scholar
• Darragh A, Snyder ML, Ptolemy AS, et al. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain. Pain Physician. 2014;17:359–366.
   PubMed Web of Science ®Google Scholar
• Milone MC. Laboratory testing for prescription opioids. J Med Toxicol. 2012;8:408–416.
   PubMedGoogle Scholar
• Linder MW, Valdes R. Mechanism and elimination of aspirin-induced interference in Emit II d.a.u. assays. Clin Chem. 1994;40:1512–1516.
   PubMed Web of Science ®Google Scholar
• Bertholf RL. Gas chromatography and mass spectrometry in clinical chemistry. In: Meyers RA, editor. Encyclopedia of analytical chemistry. Chichester, UK: John Wiley & Sons, Ltd; 2006.
   Google Scholar
• Stein SE, Scott DR. Optimization and testing of mass spectral library search algorithms for compound identification. J Am Soc Mass Spectrom. 1994;5:859–866.
   PubMed Web of Science ®Google Scholar
• Meyer GMJ, Weber AA, Maurer HH. Development and validation of a fast and simple multi-analyte procedure for quantification of 40 drugs relevant to emergency toxicology using GC-MS and one-point calibration. Drug Test Anal. 2014;6:472–481.
   PubMed Web of Science ®Google Scholar
• Grebe SK, Singh RJ. LC-MS/MS in the clinical laboratory - where to from here? Clin Biochem Rev. 2011;32:5–31.
   PubMedGoogle Scholar
• Lee Y-W. Simultaneous screening of 177 drugs of abuse in urine using ultra-performance liquid chromatography with tandem mass spectrometry in drug-intoxicated patients. Clin Psychopharmacol Neurosci. 2013;11:158–164.
   PubMed Web of Science ®Google Scholar
• Thoren KL, Colby JM, Shugarts SB, et al. Comparison of information-dependent acquisition on a tandem quadrupole TOF vs a triple quadrupole linear ion trap mass spectrometer for broad-spectrum drug screening. Clin Chem. 2016;62:170–178.
   PubMed Web of Science ®Google Scholar
• Yang HS, Wu AHB, Johnson-Davis KL, et al. Development and validation of an LC–MS/MS sulfonylurea assay for hypoglycemia cases in the emergency department. Clin Chim Acta. 2016;454:130–134.
   PubMed Web of Science ®Google Scholar
• Michely JA, Maurer HH. A multi-analyte approach to help in assessing the severity of acute poisonings - development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration. Drug Test Analysis. 2018;10:164–176.
   PubMed Web of Science ®Google Scholar
• Aygun A, Gunduz A, Turedi S, et al. Examination using LC-MS/MS determination of grayanotoxin levels in blood, urine, and honey consumed by patients presenting to the emergency department with mad honey intoxication and relations with clinical data: a preliminary study. Ann Saudi Med. 2015;35:161–164.
   PubMed Web of Science ®Google Scholar
• Al-Abri SA, Hayashi S, Thoren KL, et al. Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs. Clin Toxicol. 2013;51:444–447.
   PubMed Web of Science ®Google Scholar
• Anwar M, Turner M, Farrell N, et al. Hikers poisoned: Veratrum steroidal alkaloid toxicity following ingestion of foraged Veratrum parviflorum. Clin Toxicol. 2018;56:1–5.
   Web of Science ®Google Scholar
• Hložek T, Bursová M, Coufal P, et al. Identification and quantification of acidosis inducing metabolites in cases of alcohols intoxication by GC–MS for emergency toxicology. J Pharm Biomed Anal. 2015;114:16–21.
   PubMed Web of Science ®Google Scholar
• Han J, Moon H, Hong Y, et al. Determination of glyphosate and its metabolite in emergency room in Korea. Forensic Sci Int. 2016;265:41–46.
   PubMed Web of Science ®Google Scholar
• Lopez Nunez OF, Pizon AF, Tamama K. Ricin poisoning after oral ingestion of castor beans: a case report and review of the literature and laboratory testing. J Emerg Med. 2017;53:e67–e71.
   PubMed Web of Science ®Google Scholar
• Colby JM, Rivera J, Burton L, et al. Improvement of drug identification in urine by LC-QqTOF using a probability-based library search algorithm. Clin Mass Spectrom. 2017;3:7–12.
   Google Scholar
• Wu AH, Gerona R, Armenian P, et al. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clin Toxicol (Phila). 2012;50:733–742.
   PubMed Web of Science ®Google Scholar
• Colby JM, Thoren KL, Lynch KL. Suspect screening using LC-QqTOF is a useful tool for detecting drugs in biological samples. J Anal Toxicol. 2018;42:207–213.
   PubMed Web of Science ®Google Scholar
• Colby JM, Thoren KL, Lynch KL. Optimization and validation of high-resolution mass spectrometry data analysis parameters. J Anal Toxicol. 2017;41:1–05.
   PubMed Web of Science ®Google Scholar
• Tijdink JK, van den Heuvel J, Vasbinder EC, et al. Does on-site urine toxicology screening have an added diagnostic value in psychiatric referrals in an emergency setting? Gen Hosp Psychiatry. 2011;33:626–630.
   PubMed Web of Science ®Google Scholar
• Kroll DS, Smallwood J, Chang G. Drug screens for psychiatric patients in the emergency department: evaluation and recommendations. Psychosomatics. 2013;54:60–66.
   PubMed Web of Science ®Google Scholar
• Margolis A, Rosca P, Kurs R, et al. Routine drug screening for patients in the emergency department of a state psychiatric hospital: a naturalistic cohort study. J Dual Diagn. 2016;12:218–226.
   PubMed Web of Science ®Google Scholar
• Vakkalanka P, Rushton WF, Hardison LS, et al. Evaluation of the initiation of urine drug screens intended for use in transfer patients. Am J Emerg Med. 2014;32:1037–1040.
   PubMed Web of Science ®Google Scholar
• Riccoboni ST, Darracq MA. Does the U stand for useless? The urine drug screen and emergency department psychiatric patients. J Emerg Med. 2018;54:500–506.
   PubMedGoogle Scholar
• Sugarman JM, Rodgers GC, Paul RI. Utility of toxicology screening in a pediatric emergency department. Pediatr Emerg Care. 1997;13:194–197.
   PubMed Web of Science ®Google Scholar
• Belson MG, Simon HK, Sullivan K, et al. The utility of toxicologic analysis in children with suspected ingestions. Pediatr Emerg Care. 1999;15:383–387.
   PubMed Web of Science ®Google Scholar
• Bast RP, Helmer SD, Henson SR, et al. Limited utility of routine drug screening in trauma patients. South Med J. 2000;93:397–399.
   PubMed Web of Science ®Google Scholar
• Montague RE, Grace RF, Lewis JH, et al. Urine drug screens in overdose patients do not contribute to immediate clinical management. Ther Drug Monit. 2001;23:47–50.
   PubMed Web of Science ®Google Scholar
• Eisen JS, Sivilotti MLA, Boyd KU, et al. Screening urine for drugs of abuse in the emergency department: do test results affect physicians’ patient care decisions? CJEM. 2004;6:104–111.
   PubMedGoogle Scholar
• Tenenbein M. Do you really need that emergency drug screen? Clin Toxicol (Phila). 2009;47:286–291.
   PubMed Web of Science ®Google Scholar
• Ferrer Bosch N, Martínez Sánchez L, Trenchs Sainz de la Maza V, et al. Use of urine drug screening in the emergency department of a paediatric hospital. An Pediatr Barc Spain 2003. 2018;88:19–23.
   Google Scholar
• McAllister P, Jenner S, Laverick S. Toxicology screening in oral and maxillofacial trauma patients. Br J Oral Maxillofac Surg. 2013;51:773–778.
   PubMed Web of Science ®Google Scholar
• Monte AA, Heard KJ, Hoppe JA, et al. The accuracy of self-reported drug ingestion histories in emergency department patients. J Clin Pharmacol. 2015;55:33–38.
   PubMed Web of Science ®Google Scholar
• Kreshak AA, Wardi G, Tomaszewski CA. The accuracy of emergency department medication history as determined by mass spectrometry analysis of urine: a pilot study. J Emerg Med. 2015;48:382–386.
   PubMed Web of Science ®Google Scholar
• Lee MO, Vivier PM, Diercks DB. Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the emergency department with chest pain? J Emerg Med. 2009;37:237–241.
   PubMed Web of Science ®Google Scholar
• Liakoni E, Yates C, Dines AM, et al. Acute recreational drug toxicity: comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series. Medicine (Baltimore). 2018;97:e9784.
   PubMed Web of Science ®Google Scholar
• Boyer EW, Shannon MW. Which drug tests in medical emergencies? Clin Chem. 2003;49:353–354.
   PubMed Web of Science ®Google Scholar
• Hoffman RJ, Nelson L. Rational use of toxicology testing in children. Curr Opin Pediatr. 2001;13:183–188.
   PubMed Web of Science ®Google Scholar
• Lager PS, Attema-de Jonge ME, Gorzeman MP, et al. Clinical value of drugs of abuse point of care testing in an emergency department setting. Toxicol Rep. 2018;5:12–17.
   PubMed Web of Science ®Google Scholar
• Erdmann A, Werner D, Hugli O, et al. Focused use of drug screening in overdose patients increases impact on management. Swiss Med Wkly. 2015;145:w14242.
   PubMed Web of Science ®Google Scholar
• Schiller MJ, Shumway M, Batki SL. Utility of routine drug screening in a psychiatric emergency setting. Psychiatr Serv. 2000;51:474–478.
   PubMed Web of Science ®Google Scholar
• Akosile W, McDermott BM. Use of the urine drug screen in psychiatry emergency service. Australas Psychiatry. 2015;23:128–131.
   PubMedGoogle Scholar
• Olshaker JS, Browne B, Jerrard DA, et al. Medical clearance and screening of psychiatric patients in the emergency department. Acad Emerg Med Off J Soc Acad Emerg Med. 1997;4:124–128.
   PubMed Web of Science ®Google Scholar
• Lukens TW, Wolf SJ, Edlow JA, et al. Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Ann Emerg Med. 2006;47:79–99.
   PubMed Web of Science ®Google Scholar
• Silver B, Miller D, Jankowski M, et al. Urine toxicology screening in an urban stroke and TIA population. Neurology. 2013;80:1702–1709.
   PubMed Web of Science ®Google Scholar
• Christian MR, Lowry JA, Algren DA, et al. Do rapid comprehensive urine drug screens change clinical management in children? Clin Toxicol. 2017;55:977–980.
   PubMed Web of Science ®Google Scholar
• Nicolson NG, Lank PM, Crandall ML. Emergency department alcohol and drug screening for Illinois pediatric trauma patients, 1999 to 2009. Am J Surg. 2014;208:531–535.
   PubMed Web of Science ®Google Scholar
• Krasowski MD, Pizon AF, Siam MG, et al. Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine. BMC Emerg Med. 2009;9:5.
   PubMedGoogle Scholar
• Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine drug screening in the medical setting. Clin Chim Acta. 2002;315:125–135.
   PubMed Web of Science ®Google Scholar
• Abouchedid R, Hudson S, Thurtle N, et al. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015. Clin Toxicol. 2017;55:338–345.
   PubMed Web of Science ®Google Scholar
• Pasin D, Cawley A, Bidny S, et al. Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review. Anal Bioanal Chem. 2017;409:5821–5836.
   PubMed Web of Science ®Google Scholar
• Burish MJ, Thoren KL, Madou M, et al. Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine. Neurohospitalist. 2015;5:32–34.
   PubMed Web of Science ®Google Scholar
• Armenian P, Olson A, Anaya A, et al. Fentanyl and a novel synthetic opioid u-47700 masquerading as street “Norco in Central California: a case report”. Ann Emerg Med. 2017;69:87–90.
   PubMed Web of Science ®Google Scholar
• Al-Abri S, Meier KH, Colby JM, et al. Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels. Clin Toxicol. 2014;52:1292–1295.
   Web of Science ®Google Scholar
• Vallersnes OM, Persett PS, Øiestad EL, et al. Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway. Clin Toxicol. 2017;55:636–644.
   PubMed Web of Science ®Google Scholar
• Brandehoff N, Adams A, McDaniel K, et al. Synthetic cannabinoid “Black Mamba” infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort. Clin Toxicol. 2018;56:193–198.
   PubMed Web of Science ®Google Scholar
• Vo KT, van Wijk XMR, Lynch KL, et al. Counterfeit Norco Poisoning Outbreak - San Francisco Bay Area, California, March 25-April 5, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:420–423.
   PubMed Web of Science ®Google Scholar
• Arens AM, van Wijk XMR, Vo KT, et al. Adverse effects from counterfeit alprazolam tablets. JAMA Intern Med. 2016;176:1554–1555.
   PubMed Web of Science ®Google Scholar
• Al-Abri SA, Yang HS, Olson KR. Unintentional pediatric ophthalmic tetrahydrozoline ingestion: case files of the medical toxicology fellowship at the University of California, San Francisco. J Med Toxicol. 2014;10:388–391.
   PubMedGoogle Scholar
• Li K, van Wijk XMR, Hayashi S, et al. Anticholinergic toxicity associated with ingestion of water containing lupini bean extract. Clin Toxicol. 2017;55:687–688.
   PubMed Web of Science ®Google Scholar
• Al-Abri SA, Anderson IB, Pedram F, et al. Massive naproxen overdose with serial serum levels. J Med Toxicol. 2015;11:102–105.
   PubMed Web of Science ®Google Scholar
• Vo KT, van Wijk XMR, Wu AHB, et al. Synthetic agents off the darknet: a case of U-47700 and phenazepam abuse. Clin Toxicol (Phila). 2017;55:71–72.
   PubMed Web of Science ®Google Scholar
• Helland A, Espnes KA, Reimers A, et al. Toxicological screening of medicines and drugs of abuse in emergency cases. Tidsskr Laegeforen. 2008;128:42–45.
   PubMedGoogle Scholar
• Lee C-W, Chao Y-Y, Shiea J, et al. Ambient mass spectrometry for rapid diagnosis of psychoactive drugs overdose in an unstable patient. Am J Emerg Med. 2018;36:530.e1–530.e5.
   PubMed Web of Science ®Google Scholar
• Lee C-W, Su H, Chen P-Y, et al. Rapid identification of pesticides in human oral fluid for emergency management by thermal desorption electrospray ionization/mass spectrometry: emergent pesticide identification by ambient MS. J Mass Spectrom. 2016;51:97–104.
   PubMed Web of Science ®Google Scholar
• Lee C-W, Su H, Cai Y-D, et al. Rapid identification of psychoactive drugs in drained gastric lavage fluid and whole blood specimens of drug overdose patients using ambient mass spectrometry. Mass Spectrom. 2017;6:S0056–S0056.
   Google Scholar
• Lee C-W, Su H, Wu K-D, et al. Rapid point-of-care identification of oral medications in gastric lavage content by ambient mass spectrometry in the emergency room: identification of oral medications in gastric lavage content. Rapid Commun Mass Spectrom. 2016;30:1295–1303.
   PubMed Web of Science ®Google Scholar
• Decker BS, Goldfarb DS, Dargan PI, et al. Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol. 2015;10:875–887.
   PubMed Web of Science ®Google Scholar
• Beck O, Bäckberg M, Signell P, et al. Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats. Clin Toxicol. 2018;56:256–263.
   PubMed Web of Science ®Google Scholar
• Griswold MK, Chai PR, Krotulski AJ, et al. A novel oral fluid assay (LC-QTOF-MS) for the detection of fentanyl and clandestine opioids in oral fluid after reported heroin overdose. J Med Toxicol. 2017;13:287–292.
   PubMed Web of Science ®Google Scholar
• Backberg M, Pettersson Bergstrand M, Beck O, et al. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project. Clin Toxicol (Phila). [cited 2018 Oct 22]; [10 p.]. DOI:10.1080/15563650.2018.1506130.
   Web of Science ®Google Scholar
• Backberg M, Tworek L, Beck O, et al. Analytically confirmed intoxications involving MDMB-CHMICA from the STRIDA project. J Med Toxicol. 2017;13:52–60.
   PubMed Web of Science ®Google Scholar
• Backberg M, Westerbergh J, Beck O, et al. Adverse events related to the new psychoactive substance 3-fluorophenmetrazine - results from the Swedish STRIDA project. Clin Toxicol (Phila). 2016;54:819–825.
   PubMed Web of Science ®Google Scholar
• Backberg M, Beck O, Jonsson K-H, et al. Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clin Toxicol (Phila). 2015;53:609–617.
   PubMed Web of Science ®Google Scholar
• Helander A, Beck O, Hagerkvist R, et al. Identification of novel psychoactive drug use in Sweden based on laboratory analysis–initial experiences from the STRIDA project. Scand J Clin Lab Invest. 2013;73:400–406.
   PubMed Web of Science ®Google Scholar
• Franzen L, Backberg M, Beck O, et al. Acute intoxications involving alpha-pyrrolidinobutiophenone (alpha-PBP): results from the Swedish STRIDA project. J Med Toxicol Off J Am Coll Med Toxicol. 2018;14:265–271.
   Google Scholar
• Backberg M, Jonsson K-H, Beck O, et al. Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Drug Test Anal. 2018;10:340–349.
   PubMed Web of Science ®Google Scholar
• Wu AHB. Limitations of point-of-care testing in the ED or ICU: a role for regional centralized toxicology laboratories. Clin Pharmacol Ther. 2010;88:295–298.
   PubMed Web of Science ®Google Scholar
• Wood DM, Panayi P, Davies S, et al. Analysis of recreational drug samples obtained from patients presenting to a busy inner-city emergency department: a pilot study adding to knowledge on local recreational drug use. Emerg Med J. 2011;28:11–13.
   PubMed Web of Science ®Google Scholar
• Westwell AD, Hutchings A, Caldicott DGE. The identification and chemical characterization of a new arylcyclohexylamine, methoxetamine, using a novel Emergency Department toxicosurveillance tool: Identification and chemical characterisation of methoxetamine. Drug Test Anal. 2013;5:203–207.
   PubMed Web of Science ®Google Scholar